全文获取类型
收费全文 | 15307篇 |
免费 | 1022篇 |
国内免费 | 101篇 |
专业分类
耳鼻咽喉 | 46篇 |
儿科学 | 328篇 |
妇产科学 | 170篇 |
基础医学 | 1294篇 |
口腔科学 | 119篇 |
临床医学 | 3334篇 |
内科学 | 1019篇 |
皮肤病学 | 79篇 |
神经病学 | 589篇 |
特种医学 | 138篇 |
外科学 | 989篇 |
综合类 | 1883篇 |
预防医学 | 2421篇 |
眼科学 | 61篇 |
药学 | 3401篇 |
21篇 | |
中国医学 | 289篇 |
肿瘤学 | 249篇 |
出版年
2024年 | 22篇 |
2023年 | 335篇 |
2022年 | 748篇 |
2021年 | 907篇 |
2020年 | 785篇 |
2019年 | 873篇 |
2018年 | 814篇 |
2017年 | 553篇 |
2016年 | 557篇 |
2015年 | 615篇 |
2014年 | 1484篇 |
2013年 | 1443篇 |
2012年 | 1181篇 |
2011年 | 1307篇 |
2010年 | 959篇 |
2009年 | 697篇 |
2008年 | 572篇 |
2007年 | 499篇 |
2006年 | 385篇 |
2005年 | 301篇 |
2004年 | 227篇 |
2003年 | 199篇 |
2002年 | 159篇 |
2001年 | 128篇 |
2000年 | 102篇 |
1999年 | 92篇 |
1998年 | 59篇 |
1997年 | 34篇 |
1996年 | 29篇 |
1995年 | 34篇 |
1994年 | 20篇 |
1993年 | 16篇 |
1992年 | 11篇 |
1991年 | 5篇 |
1990年 | 8篇 |
1989年 | 5篇 |
1988年 | 8篇 |
1985年 | 41篇 |
1984年 | 64篇 |
1983年 | 25篇 |
1982年 | 27篇 |
1981年 | 20篇 |
1980年 | 22篇 |
1979年 | 17篇 |
1978年 | 7篇 |
1977年 | 10篇 |
1976年 | 7篇 |
1975年 | 7篇 |
1973年 | 2篇 |
1972年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
目的 根据乳腺癌内分泌治疗患者的症状特征,编制适用于我国乳腺癌内分泌治疗患者的症状评估量表,并检验其信效度。方法 在文献回顾及参照现有症状评估量表的基础上编制量表初始条目池;通过2轮德尔菲专家函询,形成初始版量表;通过对11例患者的认知性访谈,对量表条目进一步修订,形成临床测试版量表。便利选取2020年7月—9月在浙江省某三级甲等肿瘤医院门诊或住院的325例乳腺癌内分泌治疗患者进行问卷调查,检验量表信效度。 结果 形成的最终版乳腺癌内分泌治疗患者症状评估量表包括33个条目,探索性因子分析提取7个公因子,累计方差贡献率为68.76%;各条目内容效度指数为0.78~1.00,量表内容效度指数为0.91;内在相关性检验结果显示,量表各维度与总量表相关系数为0.58~0.79(P<0.05);维度间相关系数为0.26~0.52(P<0.05);总量表Cronbach’s α系数为0.94,重测信度为0.95,折半信度为0.84。结论 编制的乳腺癌内分泌治疗患者症状评估量表具有良好的信效度,适用于相关人群的症状测评。 相似文献
2.
3.
BackgroundSafe pharmaceutical care requires competent nurses with specific knowledge, skills and attitudes. It is unclear whether nursing students are adequately prepared to perform pharmaceutical care in practice. Mapping their pharmaceutical care competences can lead to a better understanding of the extent to which curricula fit expectations of the labour market.ObjectivesTo assess pharmaceutical care competences of final-year nursing students of different educational levels.DesignA cross-sectional survey design.SettingsIn 14 European countries, nursing schools who offer curricula for level 4 to 7 students were approached.ParticipantsThrough convenience sampling 1741 final-year student nurses of level 4 to 7 were included. Sampling strategies were country-specific.MethodsA web-platform was developed with an assessment of the level in which students mastered pharmaceutical care competences. Knowledge questions, case studies (basic/advanced level), self-reported practical skills and attitudes were evaluated.ResultsMean scores for knowledge questions differed significantly (p < 0.001) between level 5 (56/100), level 6 (68/100) and level 7 students (72/100). For basic cases level 5 students reached lower scores (64/100) compared with level 6 (71/100) and level 7 (72/100) students (p = 0.002 and p = 0.005). For more advanced cases no difference between levels was observed (overall mean 61/100). Most students (63–90 %) considered themselves skilled to perform pharmaceutical care and had positive attitudes towards their participation in pharmaceutical care (65–97 %).ConclusionsRelatively low knowledge scores were calculated for final-year student nurses. In some domains, lower levels of students might be insufficiently prepared to take up responsibilities in pharmaceutical care. Our assessment can be used as a tool for educators to evaluate how prepared nursing students are for pharmaceutical care. Its further implementation for students of different educational levels will allow benchmarking between the levels, both within and between countries. 相似文献
4.
《Research in social & administrative pharmacy》2022,18(9):3694-3698
In this paper, we argue that understanding and addressing the problem of poor-quality medical products requires a more interdisciplinary approach than has been evident to date. While prospective studies based on rigorous standardized methodologies are the gold standard for measuring the prevalence of poor-quality medical products and understanding their distribution nationally and internationally, they should be complemented by social science research to unpack the complex set of social, economic, and governance factors that underlie these patterns. In the following sections, we discuss specific examples of prospective quality surveys and of social science studies, highlighting the value of cross-sector partnerships in driving high-quality, policy-relevant research in this area. 相似文献
5.
6.
7.
8.
9.
10.
《Neuro-Chirurgie》2022,68(3):262-266
BackgroundThe prognosis for patients with recurrent glioblastoma (GBM) is dismal, and the question of repeat surgery at time of recurrence is common. Re-operation in the management of these patients remains controversial, as there is no randomized evidence of benefit. An all-inclusive pragmatic care trial is needed to evaluate the role of repeat resection.Methods3rGBM is a multicenter, pragmatic, prospective, parallel-group randomized care trial, with 1:1 allocation to repeat resection or standard care with no repeat resection. To test the hypothesis that repeat resection can improve overall survival by at least 3 months (from 6 to 9 months), 250 adult patients with prior resection of pathology-proven glioblastoma for whom the attending surgeon believes repeat resection may improve quality survival will be enrolled. A surrogate measure of quality of life, the number of days outside of hospital/nursing/palliative care facility, will also be compared. Centers are invited to participate without financial compensation and without contracts. Clinicians may apply to local authorities to approve an investigator-led in-house trial, using a common protocol, web-based randomization platform, and simple standardized case report forms.DiscussionThe 3rGBM trial is a modern transparent care research framework with no additional risks, tests, or visits other than what patients would encounter in normal care. The burden of proof remains on repeat surgical management of recurrent GBM, because this management has yet to be shown beneficial. The trial is designed to help patients and surgeons manage the uncertainty regarding optimal care.Clinical Trial Registrationhttp://www.clinicaltrials.gov. Unique identifier: NCT04838782. 相似文献